Clinical trial
AblaView® Unipolar PFA OCR-guided Feasibility Study - First in Man
NCT06700226 is registered in ClinicalTrials.gov with Medlumics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- AblaView® Unipolar PFA OCR-guided Feasibility Study - First in Man
- Lead sponsor
- Medlumics
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 8, 2024
- Completion date
- February 28, 2025
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
paroxysmal af